Biogen: Is This A Value Trap, Or Is The Great Turnaround Imminent?

Biogen Inc. ( BIIB ) is a solid profit-generating company that has seen significant declines in its earnings and share price over the past few years, particularly due to declining revenue from their legacy Multiple Sclerosis treatments. TheirI have been investing in the stock market since I was 17 years old, and over the 25+ years since I have learned the joy of compounding, the value of dividend reinvesting, and the principle that patient investing through good times and bad brings the greatest rewards. I ...